These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 26916310

  • 21. Dabigatran Concentration: Variability and Potential Bleeding Prediction In "Real-Life" Patients With Atrial Fibrillation.
    Šinigoj P, Malmström RE, Vene N, Rönquist-Nii Y, Božič-Mijovski M, Pohanka A, Antovic JP, Mavri A.
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):323-9. PubMed ID: 25981948
    [Abstract] [Full Text] [Related]

  • 22. Sensitivity of routine coagulation assays to direct oral anticoagulants: patient samples versus commercial drug-specific calibrators.
    Lim MS, Chapman K, Swanepoel P, Enjeti AK.
    Pathology; 2016 Dec; 48(7):712-719. PubMed ID: 27780603
    [Abstract] [Full Text] [Related]

  • 23. Interference of DOACs in different DRVVT assays for diagnosis of lupus anticoagulants.
    Flieder T, Weiser M, Eller T, Dittrich M, von Bargen K, Alban S, Kuhn J, Knabbe C, Birschmann I.
    Thromb Res; 2018 May; 165():101-106. PubMed ID: 29627719
    [Abstract] [Full Text] [Related]

  • 24. Laboratory measurement of the direct oral anticoagulants.
    Dale BJ, Chan NC, Eikelboom JW.
    Br J Haematol; 2016 Feb; 172(3):315-36. PubMed ID: 26492202
    [Abstract] [Full Text] [Related]

  • 25. Simultaneous Determination of Dabigatran, Rivaroxaban, and Apixaban in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry.
    Zhang M, Moore GA, Chin PKL.
    Ther Drug Monit; 2020 Jun; 42(3):473-480. PubMed ID: 32053549
    [Abstract] [Full Text] [Related]

  • 26. Simultaneous quantification of direct oral anticoagulants currently used in anticoagulation therapy.
    Foerster KI, Huppertz A, Müller OJ, Rizos T, Tilemann L, Haefeli WE, Burhenne J.
    J Pharm Biomed Anal; 2018 Jan 30; 148():238-244. PubMed ID: 29055248
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis.
    Ebner M, Birschmann I, Peter A, Härtig F, Spencer C, Kuhn J, Rupp A, Blumenstock G, Zuern CS, Ziemann U, Poli S.
    J Am Heart Assoc; 2018 Oct 02; 7(19):e009807. PubMed ID: 30371316
    [Abstract] [Full Text] [Related]

  • 37. Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levels.
    Francart SJ, Hawes EM, Deal AM, Adcock DM, Gosselin R, Jeanneret C, Friedman KD, Moll S.
    Thromb Haemost; 2014 Jun 02; 111(6):1133-40. PubMed ID: 24401946
    [Abstract] [Full Text] [Related]

  • 38. Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study.
    Vedovati MC, Mosconi MG, Isidori F, Agnelli G, Becattini C.
    J Thromb Thrombolysis; 2020 Feb 02; 49(2):251-258. PubMed ID: 31520364
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.